THE ROLE OF MOBILE APPLICATIONS AND AI IN CONTINUOUS GLUCOSE MONITORING: A COMPREHENSIVE REVIEW OF KEY SCIENTIFIC CONTRIBUTIONSTharun Anand Reddy Sure 1
Article Id - IJAIMED_01_01_002, Pages : 9-13, Date of Publication : 07, September 2023
Google Scholar Link
Scopedatabase Link : https://sdbindex.com/Document/document_search?title=THE ROLE OF MOBILE APPLICATIONS AND AI IN CONTINUOUS GLUCOSE MONITORING: A COMPREHENSIVE REVIEW OF KEY SCIENTIFIC CONTRIBUTIONS&type=1
Continuous Glucose Monitoring (CGM) has transformed diabetes management by providing real-time glucose data through mobile apps. This article explores the integration of Artificial Intelligence (AI) into CGM technology, enabling personalized insights and improved treatment outcomes. Combining mobile apps with AI opens new avenues in diabetes care, promising enhanced quality of life for patients. With ongoing technological advancements, the potential for further breakthroughs in diabetes management is vast. We stand at the threshold of an exciting era in diabetes care, offering hope for a brighter future for millions of individuals with diabetes.
Continuous Glucose Monitoring (CGM), Diabetes Management, Real-time Glucose Data, Mobile Apps, Artificial Intelligence (AI), Personalized Insights, Quality Of Life, Future Of Diabetes Care
Share and Cite:
 Heller, A., & Feldman, B. (2008). Electrochemistry in diabetes management. Chemical Reviews, 108(7), 2482-2505.
 Zhong, Q., et al. (2017). Materials advances for next-generation glucose sensors. ACS Sensors, 2(4), 468-479.
 Vaddiraju, S., et al. (2010). Technologies for continuous glucose monitoring: current problems and future promises. Journal of Diabetes Science and Technology, 4(6), 1540-1562.
 Garg, S. K., et al. (1999). Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care, 22(10), 1708-1714.
 Kaufman, F. R., et al. (2002). A pilot study of the continuous glucose monitoring system: Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care, 25(12), 2030-2034.
 Buckingham, B., et al. (2005). Real-time continuous glucose monitoring. Current Opinion in Endocrinology & Diabetes and Obesity, 12(2), 150-154.
 Oliver, N., Toumazou, C., Cass, A., & Johnston, D. (2009). Glucose sensors: a review of current and emerging technology. Diabetic Medicine, 26(3), 197-210.
 Lee, H., et al. (2017). A secure cloud computing based framework for big data information management of smart grid. Journal of Cloud Computing, 6(1), 1-13.
 Jiang, J., et al. (2018). An efficient distributed trust model for wireless body area networks. IEEE Transactions on Parallel and Distributed Systems, 29(7), 1607-1619.
 van Beers CAJ, DeVries JH, Kleijer SJ, et al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycemia (IN CONTROL): a randomized, open-label, crossover trial. The Lancet Diabetes & Endocrinology. 2016;4(11):893-902. doi:10.1016/S2213-8587(16)30193-0
 El-Laboudi A, Oliver N, Cass A, Johnston D, Borgman R, Puenpatom A, et al. Use of artificial intelligence in continuous glucose monitoring: current status, challenges and opportunities. Diabetes Technol Ther. 2021;23(S1):S-80-S-86. doi: 10.1089/dia.2021.2525.abstracts
 Zhu T, Liang G, Huang Z, et al. Machine learning algorithm for early detection of hypoglycemia based on continuous glucose monitoring. Diabetes Technol Ther. 2021;23(4):297-304. doi:10.1089/dia.2020
 Turksoy K, Quinn LT, Littlejohn E, Cinar A. An integrated multivariable artificial pancreas control system. J Diabetes Sci Technol. 2014;8(3):498-507. doi:10.1177/1932296814527559
 Bally L, Thabit H, Kojzar H, et al. Closed-loop insulin delivery for glycemic control in noncritical care. N Engl J Med. 2022;386(6):495-505. doi:10.1056/NEJMoa2107141
 Li X, Huang Z, Zhu T, et al. Using convolutional neural network to predict personalized postprandial glucose responses based on CGM data. Diabetes Technol Ther. 2021;23(4):306-313. doi:10.1089/dia.2020.0450
 Agarwal P, Wang Y, Nguyen HV, et al. Testing a conversational agent for the prevention of hypoglycemia (CAP-Hyp): protocol for a randomized controlled trial. JMIR Res Protoc. 2020;9(8):e18639. Published 2020 Aug 12. doi:10.2196/18639
- Scope Database
- Google Scholar (https://scholar.google.com)
- ResearchGate (https://www.researchgate.net/)
- Academia (https://www.academia.edu/)
- SSRN (https://www.ssrn.com/)
- Indian Citation Index (ICI) (http://www.indiancitationindex.com/)
- Advanced Science Index (https://journal-index.org/)
- ResearchBib (https://www.researchbib.com/)
Dr. Y. Omidi - Professor, Faculty of Pharmacy, School of Advanced Biomedical Sciences, Tabriz University of Medical Sciences, Iran
Ms. Vaishali Mane - Sr Product Analyst, CMS.gov [Contracting], Austin, TX
Mr. Rakesh Margam - Healthcare IT Expert, SecureKloud Technologies Inc, CA, USA
Mr. Sai Teja Makani - Senior Manager, Dev Ops, Spotter Inc, Allentown, PA, USA
Mr. Tharun Anand Reddy Sure - Senior Software Engineer - iOS, ServiceNow, Austin, Texas, USA
Mr. Rudrendu Paul - Boston University, USA
Mr. Raghava Dittakavi - Team Lead, DevOps, Tracelink.INC, MA, United States
Paper title (14 Bold)- Capital Letter
First Author1, Second Author2 (13 Bold- Times New Roman)
1(Department, College/ University Name, Address, Country Name, Email) (12)
2(Department, College/ University Name, Address, Country Name, Email) (12)
ABSTRACT (12 Bold)
The abstract should summarize the content of the paper. Try to keep the abstract below 350 words. Do not make references nor display equations in the abstract. The journal will be printed from the same-sized copy prepared by you. Your manuscript should be printed on A4 paper (21.0 cm x 29.7 cm). It is imperative that the margins and style described below be adhered to carefully. This will enable us to keep uniformity in the final printed copies of the Journal. Please keep in mind that the manuscript you prepare will be photographed and printed as it is received. Readability of copy is of paramount importance.(12)
Keywords (12 Bold) : About five key words in alphabetical order, separated by comma (12)
I. INTRODUCTION (12 BOLD)
The introduction of the paper should explain the nature of the problem, previous work, purpose, and the contribution of the paper. The contents of each section may be provided to understand easily about the paper. (12)
II. HEADINGS (12 BOLD)
The headings and subheadings, starting with "1. Introduction", appear in upper and lower case letters and should be set in bold and aligned flush left. All headings from the Introduction to Acknowledgements are numbered sequentially using 1, 2, 3, etc. Subheadings are numbered 1.1, 1.2, etc. If a subsection must be further divided, the numbers 1.1.1, 1.1.2, etc.
The font size for heading is 12 points bold face and subsections with 12 points and not bold. Do not underline any of the headings, or add dashes, colons, etc. (12)
III. INDENTATIONS AND EQUATIONS(12 BOLD)
The first paragraph under each heading or subheading should be flush left, and subsequent paragraphs should have a five-space indentation. A colon is inserted before an equation is presented, but there is no punctuation following the equation. All equations are numbered and referred to in the text solely by a number enclosed in a round bracket (i.e., (3) reads as "equation 3"). Ensure that any miscellaneous numbering system you use in your paper cannot be confused with a reference  or an equation (3) designation. (12)
IV. FIGURES AND TABLES(12 BOLD)
To ensure a high-quality product, diagrams and lettering MUST be either computerdrafted or drawn using India ink.
Figure captions appear below the figure, are flush left, and are in lower case letters.When referring to a figure in the body of the text, the abbreviation "Fig." is used. Figures should be numbered in the order they appear in the text.
Table captions appear centered above the table in upper and lower case letters. When referring to a table in the text, no abbreviation is used and "Table" is capitalized. (12). Figures and tables should be included in the running text itself
V. CONCLUSION (12 BOLD)
A conclusion section must be included and should indicate clearly the advantages, limitations, and possible applications of the paper. Although a conclusion may review the main points of the paper, do not replicate the abstract as the conclusion. A conclusion might elaborate on the importance of the work or suggest applications and extentions. (12)
VI. ACKNOWLEDGEMENTS(12 Bold)
An acknowledgement section may be presented after the conclusion, if desired.( 12)
REFERENCES (12 BOLD)
This heading is not assigned a number.
A reference list MUST be included using the following information as a guide. Only cited text references are included. Each reference is referred to in the text by a number enclosed in a square bracket (i.e., ). References must be numbered and ordered according to where they are first mentioned in the paper, NOT alphabetically.
 M Ozaki, Y. Adachi, Y. Iwahori, and N. Ishii, Application of fuzzy theory to writer recognition of Chinese characters, International Journal of Modelling and Simulation, 18(2), 1998, 112-116. (12)
 R.E. Moore, Interval analysis (Englewood Cliffs, NJ: Prentice-Hall, 1966). (12) Note that the title of the book is in lower case letters and italicized. There is no comma following the title. Place of publication and publisher are given.
Chapters in Books:
 P.O. Bishop, Neurophysiology of binocular vision, in J.Houseman (Ed.), Handbook of physiology, 4 (New York: Springer-Verlag, 1970) 342-366. (12) Note that the place of publication, publisher, and year of publication are enclosed in brackets. Editor of book is listed before book title.
 D.S. Chan, Theory and implementation of multidimensional discrete systems for signal processing, doctoral diss., Massachusetts Institute of Technology, Cambridge, MA, 1978. (12)
 W.J. Book, Modelling design and control of flexible manipulator arms: A tutorial review, Proc. 29th IEEE Conf. on Decision and Control, San Francisco, CA, 1990, 500-506 (12)
IAEME Publication charges an Article Processing Charge (APC) once an article is accepted for publication. These charges cover the costs of turning a manuscript into a finished article, as well as the costs of hosting, distributing and promoting an article.
Article Processing Charges explained
We are committed to making the costs of publishing as clear as possible and so the charges for each journal are clearly displayed on each journal`s homepage.
When a manuscript is submitted, it passes through the many different departments at Hindawi to ensure the quality checks, peer review, production and promotion of articles is carried out in a timely manner and to a high standard:
✔ The Editorial Screening team, who perform initial technical and ethical checks
✔ The Editorial team, who help the journal`s Academic Editors manage the review process
✔ The Production team, who convert the manuscript to a professionally typeset article and well-structured file format
✔ The Proofing team, who coordinate the proofing process through Hindawi`s Online Proofing System (OPS)
✔ The Editorial Quality Assurance team, who perform a final check to ensure that the manuscript and its review process adhere to the journal`s guidelines and policies
✔ Our Marketing and Communication teams, who ensure your article receives the attention it deserves.
✔ The Technology team, who build and maintain our systems, and develop new systems
The work these teams do contribute to the requirement of an APC and is why the actual amount payable varies depending on the journal in which you wish to publish your article.
IAEME Publication does not request Article Submission Charges, also called Submission Fees. These are due at the time of submission of the manuscript. Nor does IAEME charge per page or for color figures or for any other items for which other publishers are known to charge.
Sources for Article Processing Charges (APC)
Authors of an article are responsible for arranging the payment of APC. Still, that typically does not mean that authors end up paying for the publication of the article. The cost of APC is very often assumed either by the organization funding the research published in the article, or by an Open Access Publishing Fund, or by the institution at which the author is employed.
Fair Dealing - Authors and Publisher
When an author submits a manuscript for review at one of IAEME`s journals, the submitted manuscript should not have been previously published in any form and must not be currently under consideration for publication elsewhere. The manuscript should also not be submitted to any other journal during the review process at IAEME Publication. In case the review process at IAEME takes much longer than stated and the author wishes to end the review process at IAEME, he/she should get in contact with the Editorial Assistant of the journal at IAEME and come to an agreement suitable for both sides after looking at the stage of the manuscript in the review process.
With the APC specified above, the author is given an indication what the APC will be. IAEME is charging Publication Fees (APC) but not Submission Fees. This is to the benefit to authors because payments are only due once the author knows the manuscript is accepted. IAEME with editors and reviewers puts much effort in dealing with the manuscript and expects the authors to stick to the common plan of publishing the paper which is linked to payments of APC as given above at the end of the review process. The author is not legally bound at this time, but it would be seen as a strong breach of academic conduct to back off from the publication process. Once the manuscript is accepted for publication, IAEME will issue an invoice in the Paper Submission and Manuscript Tracking System. This is IAEME `s legal offer and will state the regular APC of the journal. The Corresponding Author is expected to arrange payments of the amount stated at this time. In severe cases IAEME `s Complaints Procedure can be followed and the result of this should be binding to the author.
Once an article has been accepted for publication, any Article Processing Charges on the article become due. The submitting author accepts responsibility for the Article Processing Charges, and will not issue refunds of any kind except those payments made by mistake or in excess of the amount required.
Research areas covered in the journal include, but are not limited to, the following:
- AI-based clinical decision making;
- Medical knowledge engineering;
- Knowledge-based and agent-based systems;
- Computational intelligence in bio- and clinical medicine;
- Intelligent and process-aware information systems in healthcare and medicine;
- Natural language processing in medicine;
- Data analytics and mining for biomedical decision support;
- Precision medicine
- Semantic technology for medicine
- Medical knowledge graphs and ontologies
- Machine learning and deep learning for medicine
- AI in bio-informatics
- AI for mental health
- NLP for medical data processing
- Medical data mining
- Ontology/knowledge engineering for medicine
- AI for patient data processing and management
- Epidemic outbreak prediction
- (Bio-)medical knowledge acquisition and management
- Computerized clinical practice / clinical guidelines (CPGs) and protocols
- Biomedical imaging and signal processing
- Visual analytics in biomedicine
- Clinical decision support systems (CDSS)
- Drug discovery
- Case prioritization
- Chatbots in medical science
- AI in gene editing
- New computational platforms and models for biomedicine;
- Intelligent exploitation of heterogeneous data sources aimed at supporting decision-based and data-intensive clinical tasks;
- Intelligent devices and instruments;
- Automated reasoning and meta-reasoning in medicine;
- Machine learning in medicine, medically-oriented human biology, and healthcare;
- AI and data science in medicine, medically-oriented human biology, and healthcare;
- AI-based modeling and management of healthcare pathways and clinical guidelines;
- Models and systems for AI-based population health;
- AI in medical and healthcare education;
- Methodological, philosophical, ethical, and social issues of AI in healthcare, medically-oriented human biology, and medicine.